Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Oct-24 6:34 PM View:  | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 08-Oct-24 | Purchase | 33,970 | $7.03 | $238,782.00 | 1% 2.85M to 2.89M | |
| 08-Oct-24 6:34 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 07-Oct-24 | Purchase | 11,248 | $7.22 | $81,249.90 | < 1% 2.87M to 2.88M | |
| 08-Oct-24 6:34 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 04-Oct-24 | Purchase | 16,852 | $6.77 | $114,105.00 | < 1% 2.86M to 2.87M | |
| 12-Sep-24 7:31 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 11-Sep-24 | Purchase | 50,000 | $4.75 | $237,500.00 | 2% 2.73M to 2.78M | |
| 12-Sep-24 7:31 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 10-Sep-24 | Market Purchase | 57,500 | $4.65 | $267,375.00 | 2% 2.67M to 2.73M | (9%) |
| 23-Sep-22 10:58 AM View: | Brynjelsen Sean Chief Executive Officer Director | Eton Pharmaceuticals, Inc. (ETON) | 22-Sep-22 | Private Purchase | 10,000 | $2.10 | $21,042.00 | < 1% 1.05M to 1.06M | |
| 19-Nov-21 4:09 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 17-Nov-21 | Market Sale | 25,000 | $4.67 | $116,712.00 | (1%) 2.4M to 2.38M | 3% |
| 17-Nov-21 4:33 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 16-Nov-21 | Market Sale | 12,438 | $4.86 | $60,472.30 | (< 1%) 2.5M to 2.48M | < 1% |
| 17-Nov-21 4:33 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 15-Nov-21 | Market Sale | 3,000 | $4.80 | $14,404.80 | (< 1%) 2.5M to 2.5M | (1%) |
| 09-Nov-21 4:46 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 08-Nov-21 | Market Sale | 52,661 | $6.10 | $321,285.00 | (2%) 2.55M to 2.5M | 8% |
| 09-Nov-21 4:46 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 05-Nov-21 | Market Sale | 167,701 | $6.30 | $1,056,700.00 | (6%) 2.72M to 2.55M | 11% |
| 05-Nov-21 4:13 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 04-Nov-21 | Market Sale | 85,700 | $6.44 | $551,651.00 | (3%) 2.81M to 2.72M | < 1% |
| 05-Nov-21 4:13 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 03-Nov-21 | Market Sale | 116,500 | $6.53 | $760,850.00 | (4%) 2.92M to 2.81M | 2% |
| 13-Oct-21 7:57 AM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 12-Oct-21 | Market Sale | 87,307 | $5.06 | $441,485.00 | (3%) 3.02M to 2.93M | (1%) |
| 13-Oct-21 7:57 AM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 11-Oct-21 | Market Sale | 34,101 | $5.01 | $170,716.00 | (1%) 3.04M to 3.01M | (2%) |
| 13-Oct-21 7:57 AM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 08-Oct-21 | Market Sale | 43,692 | $5.00 | $218,469.00 | (1%) 3.09M to 3.04M | (3%) |
| 20-Aug-21 4:08 PM View: | Troutman William Wilson CFO, Treasurer & Secretary | Eton Pharmaceuticals, Inc. (ETON) | 20-Aug-21 | Market Purchase | 5,000 | $4.43 | $22,150.00 | 28% 18.03K to 23.03K | (4%) |
| 20-Aug-21 4:06 PM View: | Brynjelsen Sean President & CEO Director | Eton Pharmaceuticals, Inc. (ETON) | 20-Aug-21 | Market Purchase | 10,000 | $4.32 | $43,200.00 | < 1% 1.04M to 1.05M | 3% |
| 06-Aug-21 9:53 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 06-Aug-21 | Market Sale | 345,000 | $5.84 | $2,014,870.00 | (10%) 3.43M to 3.09M | (< 1%) |
| 06-Aug-21 9:53 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 05-Aug-21 | Market Sale | 155,500 | $5.85 | $910,173.00 | (4%) 3.59M to 3.43M | (< 1%) |
| 06-Aug-21 9:53 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 04-Aug-21 | Market Sale | 104,000 | $5.75 | $598,146.00 | (3%) 3.69M to 3.59M | (2%) |
| 17-Jun-21 4:39 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 15-Jun-21 | Market Sale | 105,000 | $8.07 | $847,350.00 | (3%) 3.8M to 3.69M | 20% |
| 03-Jun-21 12:11 PM View: | Brynjelsen Sean President & CEO Director | Eton Pharmaceuticals, Inc. (ETON) | 03-Jun-21 | Market Purchase | 5,000 | $5.96 | $29,800.00 | < 1% 1.05M to 1.05M | (< 1%) |
| 27-May-21 7:34 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 27-May-21 | Market Sale | 126,000 | $8.49 | $1,069,740.00 | (3%) 3.92M to 3.8M | (1%) |
| 27-May-21 7:34 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 26-May-21 | Market Sale | 68,300 | $8.57 | $585,331.00 | (2%) 3.99M to 3.92M | (< 1%) |
| 27-May-21 7:34 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 25-May-21 | Market Sale | 48,000 | $8.53 | $409,440.00 | (1%) 4.04M to 3.99M | (< 1%) |
| 12-Apr-21 7:55 PM View: | Imprimis Pharmaceuticals, I... 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 12-Apr-21 | Market Sale | 1,518,000 | $7.00 | $10,626,000.00 | (43%) 3.5M to 1.98M | (7%) |
| 16-Oct-20 9:30 PM View: | Opaleye Management Inc. 10% Owner | Eton Pharmaceuticals, Inc. (ETON) | 16-Oct-20 | Private Purchase | 400,000 | $7.00 | $2,800,000.00 | 11% 3.64M to 4.04M | |
| 16-Feb-21 10:00 PM View: | Casamento Charles J Director | Eton Pharmaceuticals, Inc. (ETON) | 19-Mar-20 | Gift | 3,500 | -- | -- | (5%) 71.92K to 68.42K | |
| 13-Aug-19 4:04 PM View: | Brynjelsen Sean President & CEO Director | Eton Pharmaceuticals, Inc. (ETON) | 13-Aug-19 | Market Purchase | 5,000 | $6.15 | $30,750.00 | < 1% 1.04M to 1.05M | 41% |
| 12-Aug-19 4:17 PM View: | Casamento Charles J Director | Eton Pharmaceuticals, Inc. (ETON) | 09-Aug-19 | Market Purchase | 3,500 | $6.11 | $21,369.90 | 5% 68.42K to 71.92K | 42% |
| 22-May-19 4:25 PM View: | Brynjelsen Sean President & CEO Director | Eton Pharmaceuticals, Inc. (ETON) | 21-May-19 | Market Purchase | 8,600 | $7.96 | $68,431.10 | < 1% 1.04M to 1.04M | 9% |
| 22-May-19 4:25 PM View: | Brynjelsen Sean President & CEO Director | Eton Pharmaceuticals, Inc. (ETON) | 20-May-19 | Market Purchase | 1,400 | $7.78 | $10,894.80 | < 1% 1.03M to 1.04M | 11% |
| 15-Nov-18 7:23 PM View: | Brynjelsen Sean President & CEO Director | Eton Pharmaceuticals, Inc. (ETON) | 15-Nov-18 | Purchase | 10,000 | $6.00 | $60,000.00 | < 1% 1.02M to 1.03M | |
| 15-Nov-18 7:07 PM View: | Troutman William Wilson CFO, Treasurer & Secretary | Eton Pharmaceuticals, Inc. (ETON) | 15-Nov-18 | Purchase | 5,000 | $6.00 | $30,000.00 | 100% 0 to 5.0K | |
| 15-Nov-18 7:13 PM View: | Maier Paul V Director | Eton Pharmaceuticals, Inc. (ETON) | 15-Nov-18 | Purchase | 5,000 | $6.00 | $30,000.00 | 9% 54.74K to 59.74K | |
| 15-Nov-18 7:24 PM View: | Casamento Charles J Director | Eton Pharmaceuticals, Inc. (ETON) | 15-Nov-18 | Purchase | 5,000 | $6.00 | $30,000.00 | 8% 63.42K to 68.42K | |
| 15-Nov-18 7:06 PM View: | Baum Mark L Director | Eton Pharmaceuticals, Inc. (ETON) | 15-Nov-18 | Purchase Duplicate | 10,000 | $6.00 | $60,000.00 | 1% 784.75K to 794.75K | |
| 15-Nov-18 7:24 PM View: | Casamento Charles J Director | Eton Pharmaceuticals, Inc. (ETON) | 15-Nov-18 | Conversion | 8,675 | -- | -- | 16% 54.74K to 63.42K | |
| 15-Nov-18 7:23 PM View: | Brynjelsen Sean President & CEO Director | Eton Pharmaceuticals, Inc. (ETON) | 15-Nov-18 | Conversion | 24,940 | -- | -- | 2% 1000.0K to 1.02M | |
| 15-Nov-18 7:10 PM View: | Riedel Norbert G Director | Eton Pharmaceuticals, Inc. (ETON) | 15-Nov-18 | Purchase | 5,000 | $6.00 | $30,000.00 | 9% 54.74K to 59.74K |
